Comorbid conditions in Egyptian patients with migraine

References

• Steiner TJ, Stovner LJ, Jensen R, et al. On behalf of lifting the burden: the Global campaign against H. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. doi: 10.1186/s10194-020-01208-0
   PubMed Web of Science ®Google Scholar
• Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurolog Sci. 2017;372:307–315. doi: 10.1016/j.jns.2016.11.071
   PubMed Web of Science ®Google Scholar
• El-Metwally A, Toivola P, AlAhmary K, et al. The epidemiology of migraine Headache in Arab countries: a systematic review. Sci World J. 2020;2020:4790254. doi: 10.1155/2020/4790254
   Google Scholar
• Kandil MR, Hamed SA, Fadel KA, et al. Migraine in Assiut Governorate, Egypt: epidemiology, risk factors, comorbid conditions and predictors of change from episodic to chronic migraine. Neurol Res. 2016;38(3):232–241. doi: 10.1080/01616412.2015.1114232
   PubMed Web of Science ®Google Scholar
• El-Sherbiny NA, Masoud M, Shalaby NM, et al. Prevalence of primary headache disorders in Fayoum Governorate, Egypt. J Headache Pain. 2015;16(1):85. doi: 10.1186/s10194-015-0569-6
   PubMedGoogle Scholar
• El-Tallawy HN, Farghaly WM, Abdelhamed MA, et al. Prevalence of migraine in Upper Egypt. Egypt J Neurol Psychiatry Neurosurg. 2019;55(1):20. doi: 10.1186/s41983-019-0067-x
   Google Scholar
• Wang S-J, Chen P-K, Fuh J-L. Comorbidities of migraine. Front Neurol. 2010;1:16–16. doi: 10.3389/fneur.2010.00016
   PubMedGoogle Scholar
• Biçakci Ş. Comorbidity of migraine. Noro psikiyatri arsivi. 2013;50(Suppl 1):S14–S20. doi: 10.4274/Npa.y7281
   PubMedGoogle Scholar
• Buse DC, Reed ML, Fanning KM, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. doi: 10.1186/s10194-020-1084-y
   PubMed Web of Science ®Google Scholar
• Lipton RB, Fanning KM, Buse DC, et al. Identifying natural subgroups of migraine based on comorbidity and concomitant condition profiles: results of the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2018;58(7):933–947. doi: 10.1111/head.13342
   PubMed Web of Science ®Google Scholar
• The International Classification of Headache disorders. 3rd. Vol. 33, (beta version). Cephalalgia; 2013. pp. 629–808.
   Google Scholar
• El Kenawy AM, Hereher M, Robaa SM, et al. Nocturnal surface urban heat island over Greater Cairo: spatial morphology, temporal trends and links to land-atmosphere influences. Remote Sensing. 2020;12(23):12. doi: 10.3390/rs12233889
   Web of Science ®Google Scholar
• Oliveira GR, Teles BC, Brasil EF, et al. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis. 2008;14(3):389–395. doi: 10.1002/ibd.20304
   PubMed Web of Science ®Google Scholar
• Magdy R, Eid RA, Hassan M, et al. The potential impact of nutritional intake on symptoms severity in patients with comorbid migraine and irritable bowel syndrome. BMC neurol. 2022;22(1):199. doi: 10.1186/s12883-022-02723-0
   PubMed Web of Science ®Google Scholar
• Kawashima K, Fukuba N, Uemura Y, et al. Comorbid irritable bowel syndrome symptoms and headache have greater association with anxiety than depression: annual health check-up survey results. Medicine (Baltimore). 2020;99(47):e23059–e23059. doi: 10.1097/MD.0000000000023059
   PubMed Web of Science ®Google Scholar
• Chakhtoura M, Rahme M, Chamoun N, et al. Vitamin D in the middle East and North Africa. Bone Rep. 2018;8:135–146. doi: 10.1016/j.bonr.2018.03.004
   PubMedGoogle Scholar
• Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep. 2011;11(1):29–36. doi: 10.1007/s11882-010-0161-8
   PubMed Web of Science ®Google Scholar
• von Luckner A, Riederer F. Magnesium in migraine prophylaxis-is there an evidence-based Rationale? A systematic review. Headache. 2018;58(2):199–209. doi: 10.1111/head.13217
   PubMed Web of Science ®Google Scholar
• Messlinger K, Lennerz JK, Eberhardt M, et al. CGRP and NO in the trigeminal system: mechanisms and role in headache generation. Headache. 2012;52(9):1411–1427. doi: 10.1111/j.1526-4610.2012.02212.x
   PubMed Web of Science ®Google Scholar
• Rome HP Jr., Rome JD. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med. 2000;1(1):7–23. doi: 10.1046/j.1526-4637.2000.99105.x
   PubMed Web of Science ®Google Scholar
• Yamane LE, Montenegro MA, Guerreiro MM. Comorbidity headache and epilepsy in childhood. Neuropediatrics. 2004;35:99–102.
   PubMed Web of Science ®Google Scholar
• Liao J, Tian X, Wang H, et al. Epilepsy and migraine—are they comorbidity? Genes Dis. 2018;5(2):112–118. doi: 10.1016/j.gendis.2018.04.007
   PubMed Web of Science ®Google Scholar
• Rogawski MA. Migraine and epilepsy—shared mechanisms within the family of episodic disorders. In: Noebels J, Avoli M, Rogawski M, Olsen R Delgado-Escueta A, editors. Jasper’s basic mechanisms of the epilepsies. Bethesda (MD): National Center for Biotechnology Information (US); 2012. Copyright © 2012, Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen.
   Google Scholar
• Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008;65(6):709–714. doi: 10.1001/archneur.65.6.709
   PubMedGoogle Scholar
• Kern RA, Jaigobin C, Ryan M. Migraine Stroke: analysis of risk factors in migraine with and without aura. Paper presented at the The American Headache Society Annual Scientific Meeting. 2004 of Conference.
   Google Scholar
• Moisset X, Ouchchane L, Guy N, et al. Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain. 2013;154(12):2691–2699. doi: 10.1016/j.pain.2013.07.050
   PubMed Web of Science ®Google Scholar
• Pakpoor J, Handel AE, Giovannoni G, et al. Meta-analysis of the relationship between multiple sclerosis and migraine. PLoS One. 2012;7(9):e45295. doi: 10.1371/journal.pone.0045295
   PubMed Web of Science ®Google Scholar
• Kister I, Caminero AB, Monteith TS, et al. Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain. 2010;11(5):417–425. doi: 10.1007/s10194-010-0237-9
   PubMed Web of Science ®Google Scholar
• Moisset X, Giraud P, Dallel R. Migraine in multiple sclerosis and other chronic inflammatory diseases. Rev Neurol (Paris). 2021;177(7):816–820. doi: 10.1016/j.neurol.2021.07.005
   PubMed Web of Science ®Google Scholar
• Elmazny A, Hamdy SM, Abdel-Naseer M, et al. Interferon-beta-induced Headache in patients with multiple sclerosis: frequency and characterization. 2020;13:537–545. doi: 10.2147/JPR.S230680
   Google Scholar
• Pusic AD, Mitchell HM, Kunkler PE, et al. Spreading depression transiently disrupts myelin via interferon-gamma signaling. Exp Neurol. 2015;264:43–54. doi: 10.1016/j.expneurol.2014.12.001
   PubMed Web of Science ®Google Scholar
• van Olst L, Rodriguez-Mogeda C, Picon C, et al. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration. Acta Neuropathol. 2021;141(6):881–899. doi: 10.1007/s00401-021-02293-4
   PubMed Web of Science ®Google Scholar
• Assa A, Frenkel-Nir Y, Tzur D, et al. Large population study shows that adolescents with celiac disease have an increased risk of multiple autoimmune and nonautoimmune comorbidities. Acta Paediatrica. 2017;106(6):967–972. (Oslo, Norway : 1992). doi: 10.1111/apa.13808.
   PubMed Web of Science ®Google Scholar
• Gabrielli M, Cremonini F, Fiore G, et al. Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003;98(3):625–629. doi: 10.1111/j.1572-0241.2003.07300.x
   PubMed Web of Science ®Google Scholar
• van Hemert S, Breedveld AC, Rovers JM, et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol. 2014;5:241. doi: 10.3389/fneur.2014.00241
   PubMed Web of Science ®Google Scholar
• Qasim H, Nasr M, Mohammad A, et al. Dysbiosis and migraine headaches in adults with celiac disease. Cureus. 2022;14:e28346. doi: 10.7759/cureus.28346
   PubMed Web of Science ®Google Scholar
• Delaruelle Z, Ivanova TA, Khan S, et al. Male and female sex hormones in primary headaches. J Headache Pain. 2018;19(1):117–117. doi: 10.1186/s10194-018-0922-7
   PubMed Web of Science ®Google Scholar
• Charbit AR, Akerman S, Goadsby PJ. Dopamine: whatʼs new in migraine? Curr Opin Neurol. 2010;23(3):275–281. doi: 10.1097/WCO.0b013e3283378d5c
   PubMed Web of Science ®Google Scholar
• Bonati MT, Ferini-Strambi L, Aridon P, et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 2003;126(6):1485–1492. doi: 10.1093/brain/awg137
   PubMedGoogle Scholar
• Aldemir A, Yucel K, Güven H. Structural neuroimaging findings in migraine patients with restless legs syndrome. Neuroradiology. 2020;62(10):1301–1313. doi: 10.1007/s00234-020-02451-7
   PubMed Web of Science ®Google Scholar
• Welch KM, Nagesh V, Aurora SK, et al. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41(7):629–637. doi: 10.1046/j.1526-4610.2001.041007629.x
   PubMed Web of Science ®Google Scholar
• Cologno D, Cicarelli G, Petretta V, et al. High prevalence of dopaminergic Premonitory symptoms in migraine patients with Restless legs syndrome: a pathogenetic link? Neurol Sci. 2008;29(Suppl 1):S166–168. doi: 10.1007/s10072-008-0915-4
   PubMedGoogle Scholar